Amnog Benefit Assessment for Oncologic and Orphan Drugs in Germany – Implications for Price Discounts
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2335
https://www.valueinhealthjournal.com/article/S1098-3015(14)04265-X/fulltext
Title :
Amnog Benefit Assessment for Oncologic and Orphan Drugs in Germany – Implications for Price Discounts
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04265-X&doi=10.1016/j.jval.2014.08.2335
First page :
A645
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1790